Literature DB >> 35000014

HSV encephalitis associated with off-label rituximab treatment of multiple sclerosis.

Federico Montini1, Bruno Colombo1, Antonino Giordano1, Ingazio Diego Lopez1, Lucia Moiola1, Vittorio Martinelli1, Massimo Filippi2,3,4,5,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35000014     DOI： 10.1007/s10072-021-05803-0

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  1 in total

1.  A comparative study of tolerability and effects on immunoglobulin levels and CD19 cell counts with ocrelizumab vs low dose of rituximab in multiple sclerosis.

Authors:  Björn Evertsson; Tammy Hoyt; Angel Christensen; Faiez Al Nimer; John Foley; Fredrik Piehl
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-10-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.